Ad Code: 52030

Patients with systemic lupus erythematosus (SLE) experience pain from multiple factors, and the management of their pain is complex due to limited treatment options, the presence of comorbidities, or the use of multiple...

Patients with systemic lupus erythematosus (SLE) who are treated with lower doses of hydroxychloroquine (HCQ) have an increased risk for hospitalization for SLE flares, according to a study presented at the 2022 annual meeting...

For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published in Arthritis & Rheumatology to coincide with the 2022 annual meeting of the American College of...